These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2140373)

  • 1. Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring.
    Preskorn SH; Jerkovich GS
    J Clin Psychopharmacol; 1990 Apr; 10(2):88-95. PubMed ID: 2140373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressant-induced seizures and plasma drug concentration.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of assays in tricyclic antidepressant therapy.
    Clower CG
    Indiana Med; 1991 Aug; 84(8):550-2. PubMed ID: 1680895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.
    Meador-Woodruff JH; Akil M; Wisner-Carlson R; Grunhaus L
    J Clin Psychopharmacol; 1988 Feb; 8(1):28-32. PubMed ID: 3350996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring.
    Preskorn SH
    J Clin Psychiatry; 1989 Jul; 50 Suppl():34-42; discussion 43-6. PubMed ID: 2661550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressants and delirium.
    Livingston RL; Zucker DK; Isenberg K; Wetzel RD
    J Clin Psychiatry; 1983 May; 44(5):173-6. PubMed ID: 6853452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of tricyclic antidepressants.
    Preskorn SH; Dorey RC; Jerkovich GS
    Clin Chem; 1988 May; 34(5):822-8. PubMed ID: 3131042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population.
    Wroblewski BA; McColgan K; Smith K; Whyte J; Singer WD
    J Clin Psychopharmacol; 1990 Apr; 10(2):124-8. PubMed ID: 2341586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and central nervous system toxicity of antidepressants.
    Preskorn SH
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():290A-291A. PubMed ID: 1498845
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.
    Varley CK
    Paediatr Drugs; 2001; 3(8):613-27. PubMed ID: 11577926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach.
    Preskorn SH
    J Clin Psychiatry; 1986 Jan; 47(1 Suppl):24-30. PubMed ID: 2867088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
    Wilens TE; Biederman J; Baldessarini RJ; Geller B; Schleifer D; Spencer TJ; Birmaher B; Goldblatt A
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1491-501. PubMed ID: 8936916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness.
    Preskorn SH; Fast GA
    J Clin Psychiatry; 1991 Jun; 52 Suppl():23-33. PubMed ID: 1904862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of tricyclic antidepressants: a means of avoiding toxicity.
    Preskorn SH
    Psychopharmacol Ser; 1989; 7():237-43. PubMed ID: 2687862
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring tricyclic antidepressant plasma levels.
    Sato TL; Madakasira S
    Am Fam Physician; 1984 May; 29(5):199-202. PubMed ID: 6731239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses.
    Revicki DA; Palmer CS; Phillips SD; Reblando JA; Heiligenstein JH; Brent J; Kulig K
    Pharmacoeconomics; 1997 Jan; 11(1):48-55. PubMed ID: 10165526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricyclic antidepressant withdrawal syndrome.
    Garner EM; Kelly MW; Thompson DF
    Ann Pharmacother; 1993 Sep; 27(9):1068-72. PubMed ID: 8219442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toxicity of tricyclic antidepressants.
    Spiker DG
    Commun Psychopharmacol; 1978; 2(5):419-27. PubMed ID: 738020
    [No Abstract]   [Full Text] [Related]  

  • 19. Benzodiazepines co-ingestion in reducing tricyclic antidepressant toxicity.
    Eizadi-Mood N; Sabzghabaee AM; Saghaei M; Gheshlaghi F; Mohammad-Ebrahimi B
    Med Arh; 2012; 66(1):49-52. PubMed ID: 22482344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic optimisation of tricyclic antidepressant therapy.
    Furlanut M; Benetello P; Spina E
    Clin Pharmacokinet; 1993 Apr; 24(4):301-18. PubMed ID: 8491058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.